The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...
Centuries before biotechnology had a name, humans were already practicing it – breeding animals for resilience, fermenting foods and treating pain with plants. Today, that same spirit of discovery ...
The National Academies of Sciences, Engineering, and Medicine (NASEM) will convene an ad hoc planning committee to organize a workshop series with international scientists. The series will engage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results